| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2006;81:2063-2078
© 2006 The Society of Thoracic Surgeons
a Cardiovascular Surgery Service, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas
b Division of Cardiothoracic Surgery, Baylor College of Medicine, Houston, Texas
c Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, Houston, Texas
Accepted for publication January 13, 2006.
* Address correspondence to Dr LeMaire, One Baylor Plaza, BCM 390, Houston, TX 77030 (Email: slemaire{at}bcm.tmc.edu).
Presented at the Fifty-first Annual Meeting of the Southern Thoracic Surgical Association, Cancun, Mexico, Nov 4–6, 2004.
BACKGROUND: Cardiovascular disease is the main cause of morbidity and mortality in patients with Marfan syndrome. Many patients with presumed Marfan syndrome do not meet current diagnostic criteria. This study reviews the surgical aspects of aortic disease in 300 patients referred with the diagnosis of Marfan syndrome.
METHODS: During a 16-year period, 300 patients with presumed Marfan syndrome underwent 398 operations on the aorta and branch arteries, including 125 aortic root operations, 59 aortic arch repairs, 31 descending thoracic aortic repairs, and 178 thoracoabdominal aortic repairs. Based on medical record review, patients were classified as confirmed Marfan syndrome if documented features satisfied current diagnostic criteria; patients not meeting these criteria were classified as suspected Marfan syndrome.
RESULTS: There were 17 operative deaths (4.3%) after the 398 operations. Survival after the initial referral operation was 96.2% ± 1.5% at 1 year, 82.7% ± 2.4% at 5 years, and 74.6% ± 3.1% at 10 years. Presentations, operative details, and outcomes were remarkably similar in the 137 patients (45.7%) with confirmed Marfan syndrome and the 163 patients (54.3%) with suspected Marfan syndrome. Freedom from repair failure, however, was significantly better in patients with confirmed Marfan syndrome (90.3% ± 2.3% at 10 years) than in those with suspected Marfan syndrome (82.0% ± 3.1% at 10 years; p = 0.001).
CONCLUSIONS: Operative treatment of the full spectrum of aortic disease in Marfan patients enables excellent long-term survival. Similarities in surgical aspects of aortic disease suggest that patients with features of Marfan syndrome who do not meet diagnostic criteria should be managed in the same manner as patients with confirmed Marfan syndrome.
This article has been cited by other articles:
|
|
 |
|
  M. P. Siegenthaler, R. Celik, J. Haberstroh, P. Bajona, H. Goebel, K. Brehm, W. Euringer, and F. Beyersdorf Thoracic endovascular stent grafting inhibits aortic growth: an experimental study. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 17 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Coselli and S. A. LeMaire Descending and Thoracoabdominal Aortic Aneurysms Card. Surg. Adult, January 1, 2008; 3(2008): 1277 - 1298. [Full Text]
|
|
|
|
|
|
M. S. Kalkat, I. Rahman, K. Kotidis, B. Davies, and R. S. Bonser Presentation and outcome of Marfan's syndrome patients with dissection and thoraco-abdominal aortic aneurysm Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 250 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ates and A. U. Gullu Which is more appropriate for right axillary artery cannulation in acute type A aortic dissection -- directly or with graft? Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 815 - 816. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
